top of page
6 Stocks Likely to Move Big on Rare/Genetic Disease Readouts
A number of rare/genetic disease readouts are set this Q3 2025. Some of them are likely to move big. See table below for 6 of the anticipated readouts. π π 6 stocks likely to move big on rare/genetic disease readouts in Q3 β25 π $ARCT ARCT-032 / Cystic Fibrosis / Phase 2 Β» Safety findings β No SAEs, severe AEs, or dose-limiting toxicities β Dose-related increase in transient, mild, post-dose respiratory symptoms Β» PK findings: Very low systemic exposure β mRNA: all plas
Jul 16, 2025
Β
Β
Β
6 Stocks Likely to Move Big on Rare/Genetic Disease Readouts
A number of rare/genetic disease readouts are set this Q3 2025. Some of them are likely to move big. See table below for 6 of the anticipated readouts. π π
Jul 16, 2025
Β
Β
Β
April 2023 Big Moverβ’ Stocks and Movers to Watch Report
First posted 3/14/2023; last updated 4/3/23
Mar 14, 2023
Β
Β
Β
Mar 9, 2023
Β
Β
Β
March 2023 Big Moverβ’ Stocks and Movers to Watch Report
First posted 2/24/23; updated 4/3/23
Feb 23, 2023
Β
Β
Β
Upcoming Pegozafermin NASH Readout!
Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...
Feb 22, 2023
Β
Β
Β
Biopharma Mid Morning Pulse - 07/28/22
(Posted 10:15am CST) $XBI $82.01 | -1.67% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 28, 2022
Β
Β
Β
Free Biopharma Mid Morning Pulse - 07/28/22
(Posted 10:15am CST) $XBI $82.01 | -1.67% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 28, 2022
Β
Β
Β
Biopharma Mid Morning Pulse - 07/26/22
(Posted 10:05am CST) $XBI $80.41 | -0.65% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 26, 2022
Β
Β
Β
Free Biopharma Mid Morning Pulse - 07/26/22
(Posted 10:05am CST) $XBI $80.41 | -0.65% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 26, 2022
Β
Β
Β
Biopharma Mid Morning Pulse - 07/11/22
(Posted 10am CST) $XBI $81.76 | -3.16% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 11, 2022
Β
Β
Β
Free Biopharma Mid Morning Pulse - 07/11/22
(Posted 10am CST) $XBI $81.76 | -3.16% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 11, 2022
Β
Β
Β
Biopharma Daily Stock Updates - 06/27/22
$XBI $76.80 | -0.34% Table of Contents: Pipeline Updates Business Updates Covid Updates #BNTX +7.2% Pfizer and BioNTech Announce...
Jun 27, 2022
Β
Β
Β
Free Biopharma Daily Stock Updates - 06/27/22
$XBI $76.80 | -0.34% Table of Contents: Pipeline Updates Business Updates Covid Updates #BNTX +7.2% Pfizer and BioNTech Announce...
Jun 27, 2022
Β
Β
Β
Biopharma Daily Stock Updates - 06/21/22
$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...
Jun 21, 2022
Β
Β
Β
Free Biopharma Daily Stock Updates - 06/21/22
$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...
Jun 21, 2022
Β
Β
Β
Biopharma Daily Stock Updates - 06/13/22
$XBI $63.32 | -5.53% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -10.7% Novavax COVID-19...
Jun 13, 2022
Β
Β
Β
Free Biopharma Daily Stock Updates - 06/13/22
$XBI $63.32 | -5.53% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -10.7% Novavax COVID-19...
Jun 13, 2022
Β
Β
Β
Biopharma Daily Stock Updates - 06/03/22
$XBI $71.21 | +3.55% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -20% Novavax Statement on...
Jun 3, 2022
Β
Β
Β
Free Biopharma Daily Stock Updates - 06/03/22
$XBI $71.21 | +3.55% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -20% Novavax Statement on...
Jun 3, 2022
Β
Β
Β
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page